Vanguard Group Reveals Position in Mural Oncology

The Vanguard Group, Inc. has disclosed its interests and short positions in Mural Oncology plc under Form 8.3 of the Irish Takeover Rules. This form, dated June 18, 2025, outlines Vanguard's holdings in Mural Oncology's securities, detailing 773,027 ordinary shares, representing 4.48% of the company. These shares are classified as $0.01 ordinary shares.

Vanguard has also reported a sale of 64 ordinary shares at $2.47 USD per share. No transactions involving cash-settled or stock-settled derivatives were noted. There are no indemnity or dealing arrangements in place, nor any agreements regarding options or derivatives. The form clarifies that no Supplemental Form 8 accompanies this disclosure, indicating no further detailed positions or intentions related to these securities.